Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Natalizumab Shows Promise for Teens With Multiple Sclerosis
Significant reductions in average annualized relapse rates seen with treatment
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

March 3, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Cannabis Linked to Increased Risk of Cerebrovascular Events

Hospital Design Has Little Effect on Patient Satisfaction

Tracking Growth Can Facilitate Earlier ID of Celiac in Children

Majority of Doctors Yield to Parents' Vaccine Delay Requests

Suicidal Ideation Prevalent in Patients With Fibromyalgia

No Response to Statin May Mean More Rapid Atheroma Progression